Angel S Byrd1, Alexander T Toth2, Fatima Cody Stanford3,4,5. 1. Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2. Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA, USA. 3. Harvard Medical School, Boston, MA, USA. fstanford@mgh.harvard.edu. 4. MGH Weight Center, Gastrointestinal Unit-Department of Medicine, Massachusetts General Hospital, 50 Staniford Street, Suite 430, Boston, MA, 02114, USA. fstanford@mgh.harvard.edu. 5. Department of Pediatrics-Endocrinology, Massachusetts General Hospital, Boston, MA, USA. fstanford@mgh.harvard.edu.
Abstract
PURPOSE OF REVIEW: Obesity rates in the USA have reached pandemic levels with one third of the population with obesity in 2015-2016 (39.8% of adults and 18.5% of youth). It is a major public health concern, and it is prudent to understand the factors which contribute. Racial and ethnic disparities are pronounced in both the prevalence and treatment of obesity and must be addressed in the efforts to combat obesity. RECENT FINDINGS: Disparities in prevalence of obesity in racial/ethnic minorities are apparent as early as the preschool years and factors including genetics, diet, physical activity, psychological factors, stress, income, and discrimination, among others, must be taken into consideration. A multidisciplinary team optimizes lifestyle and behavioral interventions, pharmacologic therapy, and access to bariatric surgery to develop the most beneficial and equitable treatment plans. The reviewed studies outline disparities that exist and the impact that race/ethnicity have on disease prevalence and treatment response. Higher prevalence and reduced treatment response to lifestyle, behavior, pharmacotherapy, and surgery, are observed in racial and ethnic minorities. Increased research, diagnosis, and access to treatment in the pediatric and adult populations of racial and ethnic minorities are proposed to combat the burgeoning obesity epidemic and to prevent increasing disparity.
PURPOSE OF REVIEW: Obesity rates in the USA have reached pandemic levels with one third of the population with obesity in 2015-2016 (39.8% of adults and 18.5% of youth). It is a major public health concern, and it is prudent to understand the factors which contribute. Racial and ethnic disparities are pronounced in both the prevalence and treatment of obesity and must be addressed in the efforts to combat obesity. RECENT FINDINGS: Disparities in prevalence of obesity in racial/ethnic minorities are apparent as early as the preschool years and factors including genetics, diet, physical activity, psychological factors, stress, income, and discrimination, among others, must be taken into consideration. A multidisciplinary team optimizes lifestyle and behavioral interventions, pharmacologic therapy, and access to bariatric surgery to develop the most beneficial and equitable treatment plans. The reviewed studies outline disparities that exist and the impact that race/ethnicity have on disease prevalence and treatment response. Higher prevalence and reduced treatment response to lifestyle, behavior, pharmacotherapy, and surgery, are observed in racial and ethnic minorities. Increased research, diagnosis, and access to treatment in the pediatric and adult populations of racial and ethnic minorities are proposed to combat the burgeoning obesity epidemic and to prevent increasing disparity.
Authors: Marcia Schmidt; Sandra G Affenito; Ruth Striegel-Moore; Philip R Khoury; Bruce Barton; Patricia Crawford; Shari Kronsberg; George Schreiber; Eva Obarzanek; Stephen Daniels Journal: Arch Pediatr Adolesc Med Date: 2005-07
Authors: Elsie M Taveras; Thomas J Sandora; Mei-Chiung Shih; Dennis Ross-Degnan; Donald A Goldmann; Matthew W Gillman Journal: Obesity (Silver Spring) Date: 2006-11 Impact factor: 5.002
Authors: Elsie M Taveras; Matthew W Gillman; Ken Kleinman; Janet W Rich-Edwards; Sheryl L Rifas-Shiman Journal: Pediatrics Date: 2010-03-01 Impact factor: 7.124
Authors: Zongyang Mou; Thomas M Hyde; Barbara K Lipska; Keri Martinowich; Peter Wei; Chiew-Jen Ong; Lindsay A Hunter; Gladys I Palaguachi; Eva Morgun; Rujia Teng; Chen Lai; Tania A Condarco; Andrew P Demidowich; Amanda J Krause; Leslie J Marshall; Karin Haack; V Saroja Voruganti; Shelley A Cole; Nancy F Butte; Anthony G Comuzzie; Michael A Nalls; Alan B Zonderman; Andrew B Singleton; Michele K Evans; Bronwen Martin; Stuart Maudsley; Jack W Tsao; Joel E Kleinman; Jack A Yanovski; Joan C Han Journal: Cell Rep Date: 2015-10-29 Impact factor: 9.423
Authors: Angela S Kelley; Sylvia E Badon; Michael S M Lanham; Senait Fisseha; Molly B Moravek Journal: J Assist Reprod Genet Date: 2019-04-08 Impact factor: 3.412
Authors: Paul T Kröner Florit; Juan E Corral Hurtado; Karn Wijarnpreecha; Enrique F Elli; Frank J Lukens Journal: Obes Surg Date: 2019-11 Impact factor: 4.129
Authors: Alvin Chandra; Hicham Skali; Brian Claggett; Scott D Solomon; Joseph S Rossi; Stuart D Russell; Kunihiro Matsushita; Dalane W Kitzman; Suma H Konety; Thomas H Mosley; Patricia P Chang; Amil M Shah Journal: J Am Coll Cardiol Date: 2022-02-01 Impact factor: 24.094
Authors: Margaret M Gorvine; Tiffany F Haynes; S Alexandra Marshall; Cari J Clark; Nakita N Lovelady; Nickolas D Zaller Journal: J Altern Complement Med Date: 2020-12-29 Impact factor: 2.579
Authors: Jennifer Cunningham-Erves; Lanese Campbell; Calvin Barlow; Claudia Barajas; Tilicia Mayo-Gamble; Michel Perry; George Johnson Journal: Am J Health Educ Date: 2021-06-10
Authors: Tayler J James; Stephen F Sener; James D Nguyen; Marc Rothschild; Lauren Hawley; Tanu A Patel; Rachel Sargent; Adrian Dobrowolsky Journal: Obes Surg Date: 2021-07-02 Impact factor: 4.129